A&K Robotics was founded on a shared belief that robotic technologies has the potential to drastically improve Their world and quality of life. They see the future with unique eyes, pushing the boundaries of robotics and seeking real-life applications of new technologies.
A.I. VALI uses proprietary Machine Learning (ML) and Deep Learning (DL) techniques to analyze the data collected from medical images, such as endoscopy video images and tissue biopsies. Our modular A.I. tools empower our clients with accurate, reproducible and affordable platforms at a global level. These platforms have a critical impact in the early detection of cancer in order to provide the best personalized treatment model for each patient. A.I. VALI offers services in research and development, analytical validation, optimization, and validation for regulatory submissions. These services can be utilized by our clients and incorporated into the early stages of drug development through clinical trials and validation of biomarkers, or companion diagnostics (CDx), by providing precise interpretation of information on cell functioning, as well as the structure of critical proteins and biomarkers. Our extensible data science environment and toolkit was built to serve as an architectural framework and community platform for developing and distributing reusable data visualization modules and reusable multi-modality data integration pipelines. Our innovative system allows our team to develop the algorithms, validate them properly, and either commercialize them directly, or support our clients in their efforts to commercialize these products. We are eager to collaborate with researchers and clinical scientists in all medical imaging fields. If you are interested in learning more about how A.I. VALI can help develop or provide a solution for your project, please get in touch with us!
Able Innovations is developing fully automated patient transfer technology to reduce labour and injury costs and improve efficiency, dignity, and quality of life for clients and caregivers alike. Our autonomous and intelligent transfer devices will be able to lift and transfer humans in a safe, efficient, and dignified manner, with zero physical effort required from caregivers. By performing safe and effortless automated transfers, our technology will help to reduce the $30 billion annual financial burden to healthcare facilities that result from the high injury rates and labour expenditure resulting from the inefficient, unsafe, and outdated patient transfer devices in use today. Our first product, the DELTA Platform, will leverage our unique transfer method to perform automated lateral transfers in hospitals and other healthcare facilities, allowing these facilities to save millions on injury costs and optimize their labour resources to achieve the greatest clinical and social outcomes for their clients. Using this same core transfer technology, we plan to develop intelligent and robust mobility devices for long-term care and homecare use, which will enable individuals with impaired mobility to live their lives with a hereto unprecedented level of dignity and independence.
Acerta is transforming quality control by leveraging artificial intelligence to help automakers get complex products to market faster and with fewer defects. Our machine learning models are forged from industry experience and driven by data, enabling Acerta’s clients to locate the earliest indicators of future product failures. From reducing scrap and rework rates to accelerating root cause analysis, we provide automotive engineers with the tools to improve throughput and profits.
The best anti-aging resource is your own younger cells. Personalized regenerative medicine is the opportunity to leverage strategies that tap into the power of our own cells to treat our bodies. Our cells have the potential to rejuvenate skin, replenish hair, and even help fight disease. Preserving your own cells today can give you access to your own younger cells to use in revolutionary treatments for the rest of your life.
At Acrylic Robotics, we're building the world's first way to reproduce original paintings at scale. With our technology, we'll turn everyday homes, offices and public spaces into galleries with the splendour of the Louvre, the MOMA and the Met, at a fraction of the cost — all while supporting independent artists.
Ada is a computer software company that features a chatbot-based platform that helps enterprise businesses to automate customer experience. Its platform operates through both web and mobile machine learning engine that reduces support volume and empowers customers to find answers on their own. The company was founded in 2016 and headquartered in Toronto in Canada.
The AdHash Protocol cuts out the ad tech middlemen from the digital ad supply chain to create a more transparent, efficient, and privacy-focused marketplace. AdHash rebuilds the real-time bidding framework from the ground up, introducing direct ad serving and first-party data to advertisers and publishers while giving users control over their privacy and browsing experience.